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An algorithm is presented, which exhibits a computed number of rigid conformers of an input small molecule,
covering the geometric diversity in the conformational space, with minimal structural redundancy. The
algorithm calls a conformer generator, then performs an agglomerative hierarchical clustering with the
modified clustering gain as the stop criterion. The number of classes is computed without an arbitrary
parameter. A representative conformer is selected in each class, and nonrepresentative conformers are
discarded. For illustration, the algorithm has been applied on a database containing 70 ligands of the
cytochrome CYP 3A4, showing that the structural flexibility of each ligand is indeed handled via a small
number of its representative conformers. The method is valid for all small molecules.
1. INTRODUCTION
The cytochrome CYP 3A4 is a member of the P450
hemoprotein superfamily lying in the human liver. It has been
estimated that it contributes to the metabolism of roughly
50% of the drugs on the market.1 The CYP 3A4 ligands are
structurally diverse compounds of relatively high molecular
weight,2 most of them offering a wide conformational
diversity due to the flexibility around their rotatable bonds.
The active site of the CYP 3A4 is buried inside the enzyme,
so that it may be assumed that flexible ligands are submitted
to conformational changes at low energetic cost along the
trajectories inside the enzyme channels, and the bioactive
conformations are themselves not ensured to correspond to
minimal energy conformers. In the framework of in-silico
studies of several human isoforms of the P450s family,3,4
we need to consider each ligand of the CYP 3A4 as being
the union of several rigid conformers for virtual screening
purposes. Although recent QSAR studies of several P450s
substrates consider only one conformer,5 recent virtual
screening studies involve a number of conformers to be fixed
by the user, such as 50 or 100 conformers.6,7 Neither a single
rigid conformer nor an arbitrary fixed number of conformers
are satisfactory for our modeling purposes, which rely on
sophisticated geometrical shape analysis of the ligands along
the trajectories in the CYP 3A4 channels: the number of
conformers to consider should depend on the flexibility of
the ligand, rather than being a fixed number. It is why we
are looking to compute an optimal number of conformers
of each ligand with minimal geometric redundancy, but
representative of its geometric diversity within an energeti-
cally acceptable deviation from the computed minimal energy
conformer. It is expected that this approach will permit to
create an extended potential ligands database in order to
perform a realistic high throughput virtual screening.
2. METHODS
The selection of a set of conformers of a molecule is
completed in three steps: (a) generating a large set of n
conformers covering the structural diversity of geometries
of the molecule, (b) performing an agglomerative hierarchical
clustering based on an (n, n) array of distances between
conformers, and (c) eliminating the structural redundancies
via computation of an optimal number of clusters and
selection of the conformers representative of each cluster.
Ligands Preparation. A database of 70 CYP 3A4 ligands
(Figure 1) has been built by merging two ligands sets: one
from a study of CYP 3A4 drug interactions8 (34 compounds)
and the other one from a quantitative structure-activity
relationship (QSAR) study on CYP 3A49 (48 compounds).
The interest of these data sets resides in the structural and
size diversity of molecules, going from syn-Benzaldoxime
Mw 121 to Cyclosporine Mw 1203, and in their various
modes of action, recognized as either substrate or inhibitor
of CYP 3A4. Each compound of this database has been built
up and optimized under Sybyl 7.210 with conformational
analysis achieved using the genetic algorithm implemented
in Sybyl (GA conf search), or using 300-500 K molecular
dynamics runs. Optimization was completed on the more
stable conformer at the AM1/BCC level11 using Gaussian
03 suite of programs,12 despite that there is no need for high
quality 3D structures serving as starting points for conformer
generation.
Conformer Generation. The need to select diverse
conformational ensembles for virtual screening has been
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recently pointed out,13 and the size variations of conforma-
tional ensembles needed to cover the conformational space
have been intensively investigated by Borodina et al.14 using
Omega. The main differences between this latter approach
and ours are the following: (i) the method of Borodina et al.
does not involve clusters, and (ii) it is based upon an arbitrary
root mean squared deviation (rmsd) resolution which is not
needed in our present approach. In a review of conformers
generators,15 it has been concluded that geometrically similar
structures should be collected in order to increase the
probability of finding the bioactive conformation among the
generated ensembles, but it has been proved difficult to
Figure 1. Part 1 of 2.
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retrieve bioactive structures having eight or more rotatable
bonds for several conformational searching tools (Catalyst,
Confort, Flo99, and Omega). There are some web access
generators, such as Frog,16 but this is limited to 100 generated
conformers. The Sybyl software generator17 handles stere-
ochemistry constraints, offers both a systematic search and
a random search to explore the conformational space, and
has been retained in the framework of our study. The full
conformer generation procedure we have built is callable
under the Unix shell and does not require graphic inputs. It
is constituted by SPL (Sybyl programming language) mod-
ules and Unix modules. We did not use the Sybyl genetic
algorithm search because it is not callable in SPL in Sybyl
8.0.
Starting from some low energy initial conformation, the
number NRB of acyclic rotatable bonds is first computed by
Sybyl. When NRB e 2, the conformers generated by the
random search are added to those generated by the systematic
search with an increment angle of 30° . When 3 e NRB e 4,
the conformers generated by the random search are added
to those generated by the systematic search (up to 250
conformers) with an increment angle of 60° . When NRB >
4, the conformers are generated solely by the random search.
It is pointed out that the random search is useful to handle
ring conformations, discarding the value of NRB. In any case,
the cutoff of the energy increase from each initial conformer
was fixed to 50 kcal/mol to guarantee the geometric diversity.
Figure 1. Part 2 of 2. Seventy CYP 3A4 test ligands.
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At the end of the conformer generation step, it is expected
to get a sufficient coverage of the conformational space, so
that most probable conformations of the ligand are retrieved.
However, the procedure above generates a high redundancy.
Keeping a huge number of unnecessary conformations would
lead to redhibitory computational times during the virtual
screening step. The redundancy must be reduced, and only
the conformers representative of the geometric conforma-
tional diversity of the ligand have to be retained.
Clustering. Let n be the number of conformers initially
returned by the conformer generator for a given ligand. The
rms distances between each pair of conformers are computed
with the ARMS software,18 which is based on a quaternion
representation of rotations in order to ensure that only proper
rotations are allowed during the spatial alignments.19,20
ARMS returns also the maximal common 3D motif, using
the SDM algorithm.21,22
The n by n symmetric matrix of rms distances is submitted
to an ascending hierarchical clustering. Starting from n
groups of one conformer, the two closest groups are merged
and so on until it remains only one group of n conformers.
At each of the n - 1 steps of the clustering, a score function
is computed to evaluate the current set of clusters. The
maximum of this score function is used to fix the final
number K of clusters, and the hierarchical clustering is again
performed but it is stopped when there are exactly K clusters.
Then, for each cluster, a mean conformer representative of
the cluster is computed.
Given an array of distances between conformers, there
are several possible metrics to calculate the distance D
between two groups of conformers:23 when the groups j1
(size n1) and j2 (size n2) are merged, the metric defines
how the distances are recomputed between the group j1j2
and the other groups. We have used the single linkage
(D(i, j1j2) ) min{D(i, j1), D(i, j2)}), the complete linkage
(D(i, j1j2) ) max{D(i, j1), D(i, j2)}), and the following
average linkage: D2(i, j1j2) ) [n1D2(i, j1) + n2D2(i, j2)]/
(n1 + n2).
Finding an adequate stop criterion for the hierarchical
clustering is a difficult problem. Many criterions are based
on an arbitrary fixed critical distance threshold,24,25 or
calculate F as the ratio of the sample variance between
clusters to that within clusters, and then calculate the
probability of F to exceed a fixed probability level.24 The
optimal selection of such arbitrary values is difficult to
do in a virtual screening context. Some other criterions
can be found in recent books,26,27 and more can be found
in the specialized literature out of the chemistry field.28-34
Methods vary widely in their performance,35 and no clear
conclusion arose from comparative studies.29,31 We have
discarded the methods based on some arbitrary fixed
critical value, those only adequate for small size sets, and
some of those assuming an euclidean distance. In this latter
situation, it is recalled that our conformers are not located
in the space: only their rms distances are known. The rms
distance being not euclidean, we computed the inertias
by formal analogy to the euclidean case (eq 5 in Appendix
1), and we used approximate mean points when needed
(see Appendix 2). The stop criteria which were unable to
reduce the conformational redundancy (i.e., returning most
time n conformers, the stop failed), were not retained:
Dunn,34 Silhouette,27 Davies and Bouldin,32 Calinski and
Harabasz,28 Point biserial,28 Stepsize,28 and TraceW,28
McClain and Rao,28 and Hartigan.28 When mean points
are needed, they were computed as described in Appendix
2 because the space is not euclidean. Only a variant of
the clustering gain criterion36 has overcome all the
limitations above.
The clustering gain G was originally defined for data
in euclidean spaces. It is computable as follows: G )
∑j)1j)K (nj - 1)d2(gj, g), where nj is the size of the cluster j,
and d(gj, g) is the distance from its mean point to the global
mean point of the full set of the n conformers. Following
the notations of Appendix 1, G ) ∑j)1j)K (nj - 1)Tr(Bj)/nj.
Because we are not working in an euclidean space, we
computed the mean points as described in Appendix 2. The
clustering gain is a non-negative function of the number of
clusters, taking the value zero at the beginning of the
hierarchical clustering because all values nj are equal to 1
and being again null at the end of the clustering because gj
) g. Thus G has indeed a maximum, even in the noneu-
clidean case. If it happens that there are several absolute
maxima, the smallest number of clusters is retained. As an
exception, when the clustering gain is null for all n values,
the n conformers are retained. This latter situation, which is
unlikely to occur for high n values, was indeed observed
only once, for n ) 3.
After computation of the clusters, the conformer repre-
sentative of each cluster was selected such that it minimizes
the quadratic mean of its rms distances to all members of
its cluster. This quadratic mean is also a measure of the
dispersion within the cluster (see Appendix 2).
3. RESULTS
Each optimized conformer was stored in a separate mol2
file and then was submitted to the Sybyl 8.0 conformer
generator. The resulting sets of conformers were submitted
to the hierarchical clustering with the clustering gain G as
stop criterion. The number of generated conformers, the
numbers of clusters, and the dispersions of the mean cluster
points are reported in Table 1 for each of the three linkage
methods (single, average, and complete). The dispersion of
the mean cluster points is their quadratic mean distance
(clusters sizes discarded) to the global mean point, all mean
points being computed as described in Appendix 2. We
observed that these dispersions are weakly dependent on the
linkage method. The variations of the clustering gain as a
function of the number of classes have been reported for
some selected ligands in Figure 2. It is observed that the
clustering gain function takes low values for high number
of classes and then exhibits its maximum for low numbers
of classes. Some secondary maxima appear but are not
interpreted. Both the original clustering gain theory36 and
our modified clustering gain are based upon a global
maximum.
As expected, the benzopyrene has been assigned only one
representative conformer, but it is because Sybyl did not
generated any conformer in addition to the input one. In the
steroid series, progesterone and testosterone differ by one
functional group and one rotatable bond (acetyl vs hydroxy
on the carbon 17) and were assigned 13-14 conformers for
the average and the complete linkage, although the single
linkage lead respectively to 2 conformers and 21 conformers
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(Sybyl generated 42 conformers for progesterone vs 103 for
testosterone). It is assumed that the acetyl group of proges-
terone collides its spatially neighboring methyl group (carbon
18), thus lowering the number of conformers. All linkage
methods lead to attribute more representative conformers for
estriol (24-31 conformers) than for estradiol (9-10 con-
formers), although they differ only by the hydroxy group
on the carbon in position 13. This hydroxy group permitted
to multiply roughly by 2-3 the number of conformations
(one more rotatable bond). Sybyl found only three conform-
ers for ethynylestradiol. In fact, the clustering gain was null
for all values of the number of classes, i.e. from 1 to 3. It
can be noticed that the ethynyl group induces steric
constraints in the region of the quaternary carbons 13 and
17, such that it could explain why Sybyl generated few
conformers. The same kind of remark applies to mifepristone,
for which Sybyl generated only two conformers.
The macrocyclic antibiotics (cyclosporin, erythromycin,
roxythromycin) offer rather few representative conforma-
tions, particularly for the average and the complete linkage.
Cyclosporin, which is by far the largest of the three
macrocycles, was assigned four conformations for the single
and the average linkage and only three for the comp-
lete linkage (Sybyl generated 20 conformers). The same three
representative conformers were retrieved by all linkage
methods. From a steric point of view, cyclosporin is the
largest CYP 3A4 substrate in our database. In this regard,
information about its possible conformations along its
trajectory in the channels leading to the active site of the
CYP 3A4 are of high value to characterize these channels.
Simulation studies37 of cyclosporin A indicate that it could
exist several conformations of similar stability to those of
the two known experimental conformations. A study in
organic solvent38 proved that there are three experimental
conformations rather than two. There is thus an agreement
between our results and those of the literature regarding the
existence of three main conformations.
As a whole, large numbers of representative conformers
have been generated for all linkage methods for ligands
exhibiting significant acyclic chains, and particularly for the
single linkage. There is no clear trend in the linkage methods
when going from single to average and to complete linkage:
e.g., the respective number of representative conformers for
ethionamide and for clonazepam are respectively 22, 3, 17,
and 3, 3, 4 for the three linkage methods. This tells us that
the effect of the linkage method depends on the data and
that it is difficult to tell which linkage is the most adequate.
4. DISCUSSION AND CONCLUSION
It must be emphazised that an infinity of conformers is
theoretically allowed to exist in the conformational space,
and thus, there is no universal definition of the number of
representatiVe conformers, even in the framework of our
particular study. So, having different numbers of clusters for
a given chemical at the end of each clustering experiment is
not surprising, and setting some criteria for definitely ranking
the three linkage methods would be highly subjective. It is
pointed out that more variants of the clustering methods are
possible and that, for any of them, the final results are
dependent on their input data, i.e. the conformer generator.
When the conformer generator uses a Monte-Carlo method,
Table 1. Properties of conformers generated by Sybyla
ligand n Ks Ka Kc σs σa σc
acetaminophen 276 22 8 11 1.19 1.16 1.19
alprazolam 76 5 4 4 1.51 1.65 1.65
amiodarone 377 65 8 10 3.16 2.93 3.02
4-androstene-3,17-dione 111 6 9 3 0.42 0.54 0.48
astemizole 237 27 18 19 3.37 3.39 3.39
benzaldoxime 9 14 4 8 0.80 0.75 0.81
benzo(a)pyrene 1 1 1 1 0.00 0.00 0.00
budenoside 78 8 4 12 1.78 1.74 1.71
buspirone 199 43 22 10 2.84 2.87 2.64
caffeine 39 4 5 4 0.75 0.74 0.70
carbamazepine 123 12 3 9 0.79 0.72 0.67
chlorpheniramine 108 18 8 10 2.29 2.24 2.21
cisapride 192 36 13 11 3.28 3.33 3.03
clonazepam 41 3 3 4 1.45 1.45 1.28
clotrimazole 24 5 6 4 2.01 2.07 1.95
clozapine 67 5 3 7 1.89 1.78 1.91
colchicine 130 3 2 4 2.48 2.39 2.31
cortisone 30 8 6 5 1.01 1.06 0.97
cyclophosphamide 240 43 10 3 2.02 1.97 1.83
cyclosporin 21 4 4 3 2.43 2.33 2.48
dapsone 275 8 8 8 1.86 1.86 1.86
dexamethasone 45 3 4 4 1.35 1.52 1.52
dextromethorphan 179 14 20 19 0.99 0.93 0.87
diazepam 40 5 6 6 1.59 1.49 1.49
digitoxine 34 8 5 4 3.30 3.24 3.15
diltiazem 188 6 5 11 2.98 2.98 2.80
disopyramide 279 95 3 5 2.72 2.61 2.51
erythromycin 31 11 8 5 2.38 2.39 1.83
estradiol 127 9 10 9 0.80 0.77 0.80
estriol 273 24 31 29 0.42 0.43 0.43
ethionamide 296 22 14 17 1.40 1.37 1.29
ethynylestradiol 3 1 1 1 0.00 0.00 0.00
fluconazole 181 7 3 7 2.26 2.26 2.37
flutamide 7 9 8 8 1.91 1.85 1.88
gentamycin 17 22 6 5 3.12 3.06 2.74
haloperidol 218 25 8 5 2.74 2.67 2.77
hydrocortisone 32 4 5 5 1.08 1.06 1.06
ibuprofene 41 2 5 2 1.72 1.85 1.83
imipramide 144 11 5 8 2.37 2.25 2.26
itraconazole 199 21 4 9 3.94 3.92 3.56
ketoconazole 240 17 3 10 3.35 3.21 3.27
lidocaine 196 33 4 16 2.47 2.34 2.30
metoclopramide 375 21 10 2 2.55 2.49 2.50
metronidazole 9 2 2 2 1.32 1.32 1.32
miconazole 231 18 4 9 2.73 2.59 2.55
midazolam 52 4 3 3 0.94 1.04 1.04
mifepristone 2 1 1 1 0.00 0.00 0.00
nicardipine 196 7 10 3 3.39 3.12 3.50
nifedipine 112 4 4 4 2.00 2.00 2.00
nimodipine 232 43 12 4 2.76 2.78 2.79
nitrendipine 134 12 5 14 2.39 2.27 2.33
phenacetin 33 9 9 8 1.52 1.51 1.45
phenytoin 11 2 2 3 1.22 1.22 1.43
piroxicam 48 5 8 5 2.53 2.62 2.30
procainamide 285 25 9 2 2.38 2.36 2.40
progesterone 42 2 14 13 0.71 0.71 0.71
propofol 7 4 2 3 1.75 1.25 1.46
quercetin 5 2 2 2 1.11 1.11 1.11
quinidine 107 7 6 4 2.41 2.38 2.33
quinine 124 2 2 5 2.53 2.53 2.45
roxithromycin 45 12 6 3 3.00 2.99 2.92
salbutamol 171 25 3 5 2.25 2.49 2.21
sterigmatocystin 83 4 3 3 0.48 0.59 0.57
tamoxifen 359 56 10 5 3.06 2.82 2.69
terfenadine 253 79 8 4 3.40 3.37 3.36
testosterone 103 21 13 14 0.61 0.66 0.65
triazolam 52 3 3 3 1.11 1.11 1.11
verapamil 339 78 13 6 3.48 3.39 3.48
vinblastine 36 2 3 3 3.14 2.69 2.69
warfarin 86 20 7 8 2.25 2.16 2.14
a n: number of conformers generated by Sybyl. Numbers of
representative conformers: Ks (single linkage), Ka (average linkage),
Kc (complete linkage). Dispersions of clusters, in angstroms: σs
(single linkage), σa (average linkage), σc (complete linkage).
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it may be programmed to generate non-reproducible random
sequences, so that even the results of the full procedure may
fluctuate. This is the case with Sybyl, although it has been
checked at several occasions that the final numbers of
conformers vary weakly within each linkage method.
This means that an advanced study involving the com-
parison of results for various chemical libraries, for several
conformer generators, and for more clustering methods,
would imply a combinatorial comparison of a huge number
of results which is outside the scope of this study. However,
only the modified clustering gain stop criterion that we have
defined here was able to provide acceptable numbers of
conformations for all members of our CYP 3A4 ligands
database. For most compounds, other stop criterions exhibit
their optimum value either at the first step or at the last step
of the clustering, indicating that, in fact, the stop failed. In
these situations, the resulting numbers of conformers were
not accepted because they were computed with a stop
criterion which visibly does not work with our data, even if
the final result seems satisfactory in some situations (e.g.,
only one conformer for the benzopyrene). The stop criterion
must work for all compounds: we cannot prove that it works
in all situations, but we can detect that it fails in several
situations. This failure never occurred for the modified
Figure 2. Variations of the clustering gain as a function of the number of classes for some selected ligands: (O) single linkage; (×) average
linkage; (+) complete linkage.
DIVERSITY OF CYTOCHROME LIGAND CONFORMERS J. Chem. Inf. Model., Vol. 49, No. 2, 2009 335
clustering gain, whereas it occurred for the other stop criteria.
The number of conformers is expected to increase with the
number of rotatable bonds. On the other hand, the rotatable
bonds should be handled with caution: e.g., the situation of
a methyl group is different from the situation of a t-butyl
group due to steric hindrance. Counting rotatable bonds in
rings and evaluating their impact upon the number of
conformers to generate is difficult: e.g. we can flag six
rotatable C-C bonds in the cyclohexane by a symmetry
argument, but most chemists would like to retain only two
major conformations. The size of the molecule, the number
of heavy atoms, and the number of double and triple bonds
must be taken in account with care, too. A full discussion
of the number of conformers is outside the scope of this
paper.
There may be several conformations along the trajectory
from the exterior of the enzyme to its active site, which may
differ from the bioactive ones in the final enzyme-ligand
complexes and from those of the X-ray structures. This is
why we have neither reported the energies nor the rmsd from
the X-ray structures: these data are difficult to use in our
context. Finally, validating experimentally the efficiency of
our selection process is a non-trivial task, and this point will
be considered in a further study, in which further evaluation
of the method will be carried out.
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APPENDIX 1: COMPUTING INERTIAS
We consider n points in Rd, and we note g their barycenter. Let
xi (i ) 1, 2,..., n) be the respective vectors originating at g
associated to these n points. The set of the n points is partitioned
into K clusters, and the vectors associated to the points in the
cluster j are noted xij (i ) 1, 2,..., nj), nj being the number of
points in the cluster j (j ) 1, 2,..., K). We associate the mean
point of the cluster j to the vector gj ) (∑i)1i)nj xij)/nj.
The quote denoting a matrix transposition, the contribution










The contribution Bj of the cluster j to the between clusters
inertia matrix B is the following:





The contribution Tj of the cluster j to the full inertia matrix
T of the n points is Tj ) Wj + Bj and of course T ) W + B.
The inertias are the respective traces of the inertia matrices.
It can be easily checked that merging the clusters j1 and j2
decreases the between clusters inertia from the quantity [nj1nj2/
(nj1 + nj2)]d2(gj1 - gj2, gj1 - gj2), where d is the usual euclidean
distance. The total inertia being invariant, it follows that the
within clusters inertia increases from the quantity above, which
is always non-negative.
The computation of the inertia of the cluster j can be
performed only from the distances within the cluster, since we
have the following:
Tr(Wj)) [∑i1)1i1)nj ∑i2)1i2)nj d2(xi1j , xi2j )] ⁄ 2nj (5)
Thus we can compute the inertia without the knowledge of
any mean point, but it involves a double summation rather than
a single summation. The same remark applies to any subset of
the n points.
APPENDIX 2: DISTANCES TO THE MEAN POINT
The notations are those of Appendix 1, but we suppress any
cluster index for clarity, and what follows works for any set of
n points x1, x2,..., xn in Rd.






Now, we perform the minimization above on a subset of Rd







This minimum is reached for some point y ) xk (1 e k e n),
and ∆*g ∆. Then, xk is the best approximation of the barycenter
of the n points among the n points themselves, i.e. it is the point








d2(xi, g)+ nd2(xj, g)) Tr(T)+ nd2(xj, g)
Thus, d2(xj, g)) [∑
i)1
i)n







The error is the following: d2(xk, g) ) [∑i)1i)n d2(xk, xi) - Tr(T)]/
n. It is null when it happens that the barycenter falls within the
set of the n points. The calculations above extend trivially to
the continuum of points and distributions, each summation
symbol being replaced by the appropriate expectation operator.
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